These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 748894)

  • 1. [The significant genetic dose received during diagnostic radiological investigations in Poland in 1976 (author's transl)].
    Nowak B
    Pol Przegl Radiol Med Nukl; 1978; 42(6):487-90. PubMed ID: 748894
    [No Abstract]   [Full Text] [Related]  

  • 2. [The frequency of diagnostic radiological investigations in Poland (author's transl)].
    Nowak B; Jankowski J
    Pol Przegl Radiol Med Nukl; 1978; 42(1):65-8. PubMed ID: 673910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 2. Estimation of genetically significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):208-15. PubMed ID: 1066647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of the genetically significant dose from x-ray diagnosis in the Province of Varese (author's transl)].
    Mombelli L; Conte L; Inversini G; Pedroli G; Trussoni G; Visconti M
    Radiol Med; 1978 Feb; 64(2):169-78. PubMed ID: 684257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stochastic risk estimation from medical x-ray diagnostic examinations (author's transl)].
    Hashizume T; Maruyama T; Noda Y; Fukuhisa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 Sep; 40(9):885-97. PubMed ID: 7454536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Genetically significant dose from radionuclide investigation in Japan, 1971 (author's transl)].
    Hashizume T; Kato Y; Maruyama T; Kumamoto Y; Nishimura A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1973 Oct; 33(10):818-20. PubMed ID: 4526561
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influences on radiation exposure in diagnostic radiology (author's transl)].
    Kauffmann GW; Flemming K; Friedburg H; Schattenberg S
    Radiologe; 1982 May; 22(5):235-40. PubMed ID: 7089240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estimation of population doses from medical uses of radiopharmaceuticals in Japan, 1977. 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Yamaguchi H; Nishizawa K; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jul; 39(7):747-60. PubMed ID: 492934
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiation and leukemia (author's transl)].
    Ichimaru M
    Radioisotopes; 1980 Dec; 29(12):622-31. PubMed ID: 7244311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Doses of radiation absorbed by the gonads during diagnostic radiological investigations (author's transl)].
    Nowak B; Jankowski J
    Pol Przegl Radiol Med Nukl; 1978; 42(6):491-5. PubMed ID: 748895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative evaluation of risks for individuals in diagnostic radiology (author's transl)].
    Iinuma TA; Tateno Y; Hashizume T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):476-84. PubMed ID: 7422475
    [No Abstract]   [Full Text] [Related]  

  • 12. [The risk of neoplasm induction in the Polish population by diagnostic radiological investigations (author's transl)].
    Jankowski J
    Pol Przegl Radiol Med Nukl; 1980; 44(3):189-93. PubMed ID: 7433169
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of doses to patients in X-ray diagnostics in Poland.
    Staniszewska MA
    Int J Occup Med Environ Health; 1999; 12(4):305-30. PubMed ID: 10703180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Population doses from beam therapy in Japan 1978. Part 2. Estimation of genetically significant dose, per caput mean bone marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Shiragai A; Noda Y; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1980 May; 40(5):466-75. PubMed ID: 7422474
    [No Abstract]   [Full Text] [Related]  

  • 15. [Estimation of population doses from diagnostic medical examinations in Japan, 1974. 3. Per caput mean marrow dose and leukemia significant dose (author's transl)].
    Hashizume T; Maruyama T; Kumamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Mar; 36(3):216-24. PubMed ID: 1066648
    [No Abstract]   [Full Text] [Related]  

  • 16. [Population doses from beam-therapy in Japan, 1978. Part 3. Estimation of malignancy significant dose and fatal malignant risk (author's transl)].
    Hashizume T; Matsuzawa H; Maruyama T; Kawachi K; Noda Y; Shiragai A; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981 Feb; 41(2):158-67. PubMed ID: 7267299
    [No Abstract]   [Full Text] [Related]  

  • 17. An update of the frequency and type of diagnostic x-ray examinations in Poland.
    Staniszewska MA; Jankowski J
    Int J Occup Med Environ Health; 1999; 12(2):127-34. PubMed ID: 10465903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications of angiographic investigations in the light of an inquiry in the Polish radiological centres during the period from March 1 to May 30, 1976. (author's transl)].
    Klamut M; Szmigielski W; Szczerbo-Trojanowska M; Bieganowska-Klamut Z
    Pol Przegl Radiol Med Nukl; 1977; 41(3):205-7. PubMed ID: 887476
    [No Abstract]   [Full Text] [Related]  

  • 19. [The problem of radiological protection of out patients].
    Kieszkowski Z
    Pol Przegl Radiol Med Nukl; 1970; 34(2):281-9. PubMed ID: 5431328
    [No Abstract]   [Full Text] [Related]  

  • 20. [Assessment of the genetically significant doses due to x-ray studies conducted in the Azerbaijani SSR].
    Kafarov RG
    Gig Sanit; 1975 Sep; (9):111-3. PubMed ID: 129354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.